Aavogen
Organization
People
Sources: reporter.nih.gov
Grants and prizes
National Institute of Diabetes and Digestive and Kidney Diseases
R43, Preclinical validation of AVGN7 for treating obesity and type 2 diabetes mellitus., R43DK145239, US$350k, 2025–2027, Sep 5, 2025
Sources: reporter.nih.gov